- Cash receipts from customers $298k (up from previous quarter...

- Cash receipts from customers $298k (up from previous quarter $273K)
That's 4 out of the past 5 quarters where cash receipts have been between $240k and $300k - there was one anomaly quarter which was approx $650k but I can't remember the details.
Basically, 'no progress' ...

- soft launch of Company's plant-based skincare products scheduled for November 2021 at the Hemp, Health and Innovation Expo
They're sponsoring that Expo !

- Company's first order of Canntab's cannabinoid hard pill formulations has been received
It's well documented how long that took from leaving Canada to clearing Customs, plus no sign of the rest of the shipment being on it's way yet...
**PLUS - and the Company is waiting for an independent third party’s lab results to allow
the sales launch to commence
WHY would this be necessary ??! To check the chemical content of the pills when it's already come from a highly regulated source ?? Is this 'independent' third party linked to a specific potential client ??

- Western Sydney University has completed the first draft clinical trial protocol
It's a 'draft' of a 'protocol' - the 'first' draft !
It looks more like a few ideas written on the back of a matchbox ...

If we skip through attempted spin and smoke, it's easy to see the reality (imo)